Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension-Reference-Cited by-同舟云学术

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension

Published:2014-08 Issue:8 Volume:32 Page:1700-1707
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Mancia Giuseppe,Coca Antonio,Chazova Irina,Girerd Xavier,Haller Hermann,Pauletto Paolo,Pupek-Musialik Danuta,Svyshchenko Yevgeniya

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference32 articles.

1. 2013ESHESC Guidelines for the management of arterial hypertension.;Mancia;J Hypertens,2013

2. ACCFAHA 2011 Expert Consensus Document on Hypertension in the Elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.;Aronow;J Am Coll Cardiol,2011

3. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.;Wald;Am J Med,2009

4. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.;Weber;Lancet,2004

5. Fixed-dose combinations improve medication compliance: a meta-analysis.;Bangalore;Am J Med,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

2. Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA;Current Medical Research and Opinion;2023-01-20

3. Calciumkanalblocker;Arzneiverordnungs-Report 2021;2021

4. Calciumantagonisten;Arzneiverordnungs-Report 2020;2020

5. Effectiveness of two‐drug therapy versus monotherapy as initial regimen in hypertension: A propensity score‐matched cohort study in the UK Clinical Practice Research Datalink;Pharmacoepidemiology and Drug Safety;2019-09-03